Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 4Recruiting 3Not yet recruiting 2Withdrawn 1Unknown 1Terminated 1Suspended 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Lung Neoplasms 1Hematologic Neoplasms 1Hematologic Diseases 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Fluorouracil 34Leucovorin 31Oxaliplatin 25Irinotecan 19Capecitabine 13Folfox protocol 11Chemotherapy, Adjuvant 11Cetuximab 11Bevacizumab 9Neoadjuvant Therapy 8XELOX 7Laparoscopy 7Drug Therapy 7Endoscopic Mucosal Resection 5Colonoscopy 5Surgical Procedures, Operative 4Gemcitabine 4Tegafur 3Radiotherapy 3Propofol 3Preoperative Exercise 3Panitumumab 3Fentanyl 3Curcumin 3Colectomy 3Celecoxib 3Aspirin 3raltitrexed 2Surveys and Questionnaires 2Sodium Chloride 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colonic Neoplasms × Specimen Handling × Clear all
NCT06017141 2023-08-30

Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study

University of Kansas Medical Center

Phase 2 Unknown
80 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡